glp 1 reduce cancer risk GLP-1 receptor agonists show anti-cancer benefits beyond weight loss Can GLP-1 Medications Reduce Breast
Description
Our current and previous findings in mice suggest that cell GLP-1R signaling promotes the secretion of a factor that can act on cells to turn on cell PCSK1 expression (24)
In 2014, there were 422 million people with diabetes (8.5% of the global population) [4] and this number is expected to rise to 592 million by 2035 [5]
Yet the real-world data tells a different story
It should be the centre of the conversation
Therefore, studies that extend the follow-up time and increase the sample size to observe the role of GLP-1 in atherosclerosis can be further developed
Not just obesity: GLP-1 receptor agonists advance on addiction
